|
Volumn 10, Issue 6, 2004, Pages 649-
|
Erratum: Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer (Nature Medicine (2004) 10 (145-147))
a a a a a a a a a a a a a a a a a a a a more..
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ERRATUM;
ERROR;
PRIORITY JOURNAL;
|
EID: 2942738883
PISSN: 10788956
EISSN: None
Source Type: Journal
DOI: 10.1038/nm0604-649c Document Type: Erratum |
Times cited : (12)
|
References (0)
|